Dr. Saumya Pant is the Vice President of Bioinformatics at Neogenomics, where she leads a team focused on bioinformatics and data analysis for NGS clinical diagnostics, translational research, and clinical trials. With a Ph.D. in Cell and Molecular Biology from Rutgers, Saumya pioneered circulating nucleic acid liquid biopsy tests during her postdoctoral work at Roche. She is an expert in genomics, NGS, and companion diagnostic development, having led teams at Merck and Bristol Myers Squibb, contributing to key innovations in precision medicine. Before Neogenomics, she led clinical development at PathAI, supporting drug and diagnostic programs in oncology, metabolic, and immune diseases. Saumya is passionate about transforming patient care through drug R&D, diagnostic development, and data science.